Ditchcarbon
  • Customers
  1. Organizations
  2. Zai Lab
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated 19 days ago

Zai Lab

Company website

Zai Lab Limited, commonly referred to as Zai Lab, is a prominent biopharmaceutical company headquartered in China. Founded in 2014, the company has rapidly established itself as a leader in the development of innovative therapies, focusing primarily on oncology, autoimmune diseases, and infectious diseases. With a strong operational presence in both China and the United States, Zai Lab is committed to addressing unmet medical needs through its robust pipeline of novel drug candidates. The company’s core offerings include a range of proprietary and partnered products, distinguished by their unique mechanisms of action and potential to improve patient outcomes. Zai Lab has achieved significant milestones, including successful collaborations with global pharmaceutical leaders and the launch of several key therapies in the Chinese market. Recognised for its commitment to innovation, Zai Lab continues to strengthen its position in the competitive biopharmaceutical landscape.

DitchCarbon Score

How does Zai Lab's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

28

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Zai Lab's score of 28 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.

53%

Let us know if this data was useful to you

Zai Lab's reported carbon emissions

In 2022, Zai Lab reported total carbon emissions of approximately 73,481,000 kg CO2e. This figure includes Scope 1 emissions of about 19,000 kg CO2e, Scope 2 emissions of approximately 3,951,000 kg CO2e, and significant Scope 3 emissions, which totalled around 64,511,000 kg CO2e. The Scope 3 emissions breakdown includes capital goods (about 8,786,000 kg CO2e), business travel (approximately 6,542,000 kg CO2e), and purchased goods and services (around 51,051,000 kg CO2e). Zai Lab has committed to near-term emissions reduction targets, although specific numerical targets have not been disclosed. The company is not currently committed to a net-zero target. Their emissions data is sourced directly from Zai Lab Limited, with no cascading from a parent organisation. In 2021, Zai Lab's emissions were reported at approximately 3,546,000 kg CO2e for Scope 1 and 2 combined, while in 2020, the company reported Scope 2 emissions of about 1,407,800 kg CO2e. The company has shown a commitment to transparency in its emissions reporting, as evidenced by its published ESG Trust Reports. Zai Lab operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector and is headquartered in China. The company continues to work towards improving its sustainability practices and reducing its carbon footprint in alignment with industry standards.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20212022
Scope 1
28,400
00,000
Scope 2
3,536,600
0,000,000
Scope 3
-
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Zai Lab's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Zai Lab is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Zai Lab is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Astra Tech GesmbH (Austria)

AT
Updated about 1 month ago

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Novimmune SA

CH
•
Research and development services (73)
Updated 1 day ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 7 hours ago

Rocca & Partners Stichting Administratiekantoor Aandelen San Faustin

NL
Updated 11 days ago

Phanes Therapeutics, Inc.

US
•
Research and development services (73)
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250829.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy